Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation

Cancer Research

Volumn 72, Issue 21, 2012, Pages 5635-5645

  Yi, Lan ^a,c   Lu, Chiwei ^b   Hu, Wenwei ^a,c   Sun, Yvonne ^a,c   Levine, Arnold J ^a,c,d  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; MYC PROTEIN; PROTEIN P21; PROTEIN P53; PUMA PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; CANCER CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EPIGENETICS; GENE; GENETIC REGULATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; P21 GENE; P53 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC CELL; STOCHASTIC MODEL;

ANIMALS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; FLUORESCENT ANTIBODY TECHNIQUE; HCT116 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR REPROGRAMMING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868224979     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1451     Document Type: Article

References (36)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72.
3. Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007;1:245-7.
4. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-7.
5. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Repro-gramming of human somaticcellsto pluripotencywith definedfactors. Nature 2008;451:141-6.
6. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vitro reprogramming offibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-24.
7. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
8. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, et al. Immortalization eliminates a roadblockduring cellular reprogramming into i PS cells. Nature 2009;460:1145-8.
9. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, et al. A p53-mediated DNA damage response limits reprogramming to ensure i PS cell genomic integrity. Nature 2009;460:1149-53.
10. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, et al.The Ink4/Arf locus is a barrier for i PS cell reprogramming. Nature 2009;460:1136-9.
11. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009;460:1140-4.
12. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460:1132-5.
13. Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, Geti I, et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 2009;23:2134-9.
14. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, et al. Direct cell reprogramming is a stochastic process amenable to accel-eration. Nature 2009;462:595-601.
15. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, et al. Loss of genomic methylation causes p53-depen-dent apoptosis and epigenetic deregulation. Nat Genet 2001;27:31-9.
16. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40: 499-507.
17. Mizuno H, Spike BT, Wahl GM, Levine AJ.Inactivationof p53in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A 2010;107:22745-50.
18. Markert EK, Mizuno H, Vazquez A, Levine AJ. Molecularclassification of prostate cancer using curated expression signatures. Proc Natl Acad Sci U S A2011;108:21276-81.
19. Harvey DM, Levine AJ. p53 alteration is a common event in the spontaneous immortalization ofprimary BALB/cmurineembryofibro-blasts. Genes Dev 1991;5:2375-85.
20. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007;2: 3081-9.
21. Mali P, Ye Z, Chou BK, Yen J, Cheng L An improved method for generating and identifying human induced pluripotent stem cells. Methods Mol Biol 2010;636:191-205.
22. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, et al.Gain of function mutations in p53. Nat Genet 1993;4:42-6.
23. Li F, He Z, Shen J, Huang Q, Li W, Liu X, et al. Apoptotic caspases regulate induction of i PSCs from human fibroblasts. Cell Stem Cell 2010;7:508-20.
24. Berger SL. Keeping p53 in check: a high-stakes balancing act. Cel 2010;142:17-9.
25. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal repro-duction through LIF. Nature 2007;450:721-4.
26. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995;5: 931-6.
27. Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010;2:a001107.
28. Sarig R, Rivlin N, Brosh R, Bornstein C, Kamer I, Ezra O, et al. Mutant p53 facilitates somatic cell reprogramming and augments the malig-nant potential of reprogrammed cells. J Exp Med 2010;207:2127-40.
29. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G. p63and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2010;2:a004887.
30. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, et al. Live cell imaging distinguishes bona fide human i PS cells from partially reprogrammed cells. Nat Biotechnol 2009;27:1033-7.
31. Oren M, Reich NC, Levine AJ. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol Cell Biol 1982;2:443-9.
32. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, Jaenisch R, et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 1998;8:145-55.
33. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-71.
34. Maimets T, Neganova I, Armstrong L, Lako M. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008;27:5277-87.
35. Meek DW, Anderson CW. Posttranslational modification of p53: coop-erative integrators offunction. Cold Spring Harb Perspect Biol 2009;1: a000950.
36. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.